Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VIIBRYD vs VIMSELTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VIIBRYD vs VIMSELTINIB: Safety Overview

Metric VIIBRYD VIMSELTINIB
Total FAERS Reports 270 170
Deaths Reported 6 0
Death Rate 2.2% N/A
Hospitalizations 18 5
Average Patient Age 52.6 yrs 45.6 yrs
% Female Patients N/A 55.4%
FDA Approval Date N/A Feb 14, 2025
Manufacturer N/A Deciphera Pharmaceuticals, LLC
Route N/A ORAL
Marketing Status N/A Prescription